The ‘Unintended Consequences’ Of UK's New Pricing Scheme

 
• By Ian Schofield

Issues raised in the first six months of the new VPAG include potential adverse impacts on both older and newer innovative drugs, as well as uncertainties over the “exceptional circumstances” clause that allows requests for price increases or cuts in repayment rates.

Pile of different colouful pills placed around two british pound coins. Illustrative for cost of medical bills, treatment, health insurance and other subjects
The UK's new drug pricing and access scheme was introduced in January • Source: Shutterstock

More from Europe

More from Geography